Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
3
Issued Date
2025-01-01
Resource Type
ISSN
13237799
eISSN
14401843
Scopus ID
2-s2.0-105012760169
Journal Title
Respirology
Rights Holder(s)
SCOPUS
Bibliographic Citation
Respirology (2025)
Suggested Citation
Rhee C.K., Ko F.W.S., Giap V.V., Kawamatawong T., Lee J.K., Matsunaga K., Haja Mydin H., Pang Y.K., Perng D.W., Salazar-Supe M., Shibata Y., Sim D., Tanabe N., Tee A., Wang H.C., Wu Y.W., Yunus F. Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly. Respirology (2025). doi:10.1111/resp.70103 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/111664
Title
Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
Author's Affiliation
Chinese University of Hong Kong
National Yang-Ming University Taiwan
National Taiwan University Hospital
Universitas Indonesia
Taipei Veterans General Hospital
Graduate School of Medicine
Fukushima Medical University
Yuan Ze University
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul Metropolitan Government - Seoul National University Borame Medical Center
Ramathibodi Hospital
Far Eastern Memorial Hospital
Yamaguchi University Graduate School of Medicine
Changi General Hospital
National Heart Centre Singapore
Hanoi Medical University
University of Malaya Medical Centre
Bach Mai Hospital
Pantai Holdings Sdn Bhd
Philippine Heart Center
National Yang-Ming University Taiwan
National Taiwan University Hospital
Universitas Indonesia
Taipei Veterans General Hospital
Graduate School of Medicine
Fukushima Medical University
Yuan Ze University
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul Metropolitan Government - Seoul National University Borame Medical Center
Ramathibodi Hospital
Far Eastern Memorial Hospital
Yamaguchi University Graduate School of Medicine
Changi General Hospital
National Heart Centre Singapore
Hanoi Medical University
University of Malaya Medical Centre
Bach Mai Hospital
Pantai Holdings Sdn Bhd
Philippine Heart Center
Corresponding Author(s)
Other Contributor(s)
Abstract
Chronic obstructive pulmonary disease (COPD) has a high burden in Asia. These patients are also susceptible to various cardiovascular diseases (CVD). A panel of expert Asian pulmonologists explored the published literature to understand the impact of COPD and CVD on each other and to identify the cardiopulmonary risk factors in the region. The experts concluded that an elevated risk of all-cause mortality and acute cardiovascular events persists for up to 2 years following moderate and severe COPD exacerbations, with the risk of death being highest in the first 30 days after the exacerbation. High smoking rate (especially in males), high indoor and outdoor air pollution in Asia, relatively low vaccination rate in Asia (especially in low- and middle-income countries), and relatively low rate of utilisation of inhaler medications impact the cardiopulmonary risk in Asia.